1684. Hospital Costs and Reimbursement in Patients with Resistant Enterobacteriaceae (ENT) Urinary Tract Infection (UTI) in the United States (US): A Multicenter Analysis

BACKGROUND: Rates of fluoroquinolone resistance (FQ-R) and third-generation cephalosporin resistance/extended-spectrum beta-lactamases (ESBL+) are rising. These pathogens generally retain susceptibility to intravenous (IV) carbapenems; however, the loss of susceptibility to commonly used oral (PO) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Melnick, David, Jain, Akash, Gupta, Vikas, Sulham, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778195/
http://dx.doi.org/10.1093/ofid/ofaa439.1862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778195/
http://dx.doi.org/10.1093/ofid/ofaa439.1862

Ejemplares similares